Analyze Diet

Effect of the somatostatin analogue octreotide on gastric fluid pH in ponies.

Abstract: The effect of the somatostatin analogue, octreotide, on gastric fluid pH was investigated in 4 ponies. Gastric fluid pH was determined after SC administration of octreotide or physiologic saline solution (control). A baseline sample of fluid was obtained, the agent was given, and 8 additional samples were collected hourly. Administration of octreotide at all dosages tested (0.1, 0.5, 1.0, and 5.0 micrograms/kg of body weight) increased gastric pH to > 5.0. Baseline values were consistently 4.0 for 2.4 +/- 1.2, 4.8 +/- 0.8, 5.7 +/- 1.3, and 5.4 +/- 2.6 (mean +/- SD) continuous hours, respectively. Treatment at all dosages increased the pH of gastric fluid, compared with control values. The duration of the increase in pH was significantly (P < 0.05) different than that of the control treatment, even for the lowest dosage, 0.1 microgram/kg.
Publication Date: 1992-10-01 PubMed ID: 1456527
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigated the impact of Octreotide, a drug similar to a natural hormone in the body, on the acidity level of stomach fluid in ponies. Results indicated that administration of Octreotide caused an increase in the gastric fluid pH in the studied ponies, suggesting a reduction in stomach acidity.

Introduction to Octreotide and Gastric Fluid pH

  • The study revolves around Octreotide, a synthetic analogue of somatostatin─ a hormone that inhibits the release of certain other hormones in the body. Octreotide is often used in medical practices to treat symptoms associated with particular types of tumors.
  • Gastric fluid pH is a measure of the acidity or alkalinity of the stomach fluid. A lower pH indicates higher acidity and vice versa. This is of interest because a change in gastric pH can affect the digestion process and potentially cause discomfort or disorders in the stomach.

Methodology of the Research

  • The research was conducted on four ponies. Each pony was administered Octreotide at different dosages via subcutaneous injection then compared with a control administration of a physiological saline solution which have no therapeutic effect.
  • A baseline sample of gastric fluid was taken before Octreotide administration and then hourly samples were collected up to 8 hours afterwards to gauge the drug’s effectiveness over time.

Findings of the Research

  • All dosages of Octreotide tested (0.1, 0.5, 1.0, and 5.0 micrograms/kg of body weight) were found to increase the gastric fluid pH to levels greater than 5.0, indicating a decrease in acidity of the stomach. Prior to administration, the ponies’ gastric pH was consistently less than 2.7, highlighting a fairly acidic environment.
  • The duration for which the increased gastric pH levels were maintained varied depending on the dosage but was significantly longer than in the control treatment across all dosages. Even the smallest dosage, 0.1 microgram/kg, showed a significant increase in duration.

Conclusion

  • The study concludes that Octreotide administration can lead to a decrease in gastric acidity in ponies, as evidenced by the increase in gastric fluid pH. This suggests the potential therapeutic value of Octreotide in managing stomach disorders associated with excessive acidity, although further studies are needed to confirm this finding’s applicability in clinical settings.

Cite This Article

APA
Sojka JE, Weiss JS, Samuels ML, You GM. (1992). Effect of the somatostatin analogue octreotide on gastric fluid pH in ponies. Am J Vet Res, 53(10), 1818-1821.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 53
Issue: 10
Pages: 1818-1821

Researcher Affiliations

Sojka, J E
  • Department of Veterinary Clinical Studies, Purdue University, West Lafayette, IN 47907.
Weiss, J S
    Samuels, M L
      You, G M

        MeSH Terms

        • Animals
        • Female
        • Gastric Acidity Determination / veterinary
        • Gastric Juice / drug effects
        • Horses / metabolism
        • Octreotide / pharmacology

        Citations

        This article has been cited 3 times.
        1. Hewetson M, Tallon R. Equine Squamous Gastric Disease: Prevalence, Impact and Management.. Vet Med (Auckl) 2021;12:381-399.
          doi: 10.2147/VMRR.S235258pubmed: 35004264google scholar: lookup
        2. Frank N, Hermida P, Sanchez-Londoño A, Singh R, Gradil CM, Uricchio CK. Blood Glucose and Insulin Concentrations after Octreotide Administration in Horses With Insulin Dysregulation.. J Vet Intern Med 2017 Jul;31(4):1188-1192.
          doi: 10.1111/jvim.14718pubmed: 28503791google scholar: lookup
        3. Holtenius K. Effects of the long-acting somatostatin analogue octreotide on abomasal function and plasma level of insulin and glucagon in sheep.. Acta Vet Scand 1994;35(3):235-41.
          doi: 10.1186/BF03548328pubmed: 7847192google scholar: lookup